Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Change in Accured Expenses (2020 - 2025)

Historic Change in Accured Expenses for Sotera Health (SHC) over the last 6 years, with Q3 2025 value amounting to $27.8 million.

  • Sotera Health's Change in Accured Expenses rose 7853.79% to $27.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.4 million, marking a year-over-year increase of 9721.17%. This contributed to the annual value of $7.1 million for FY2024, which is 10325.71% up from last year.
  • Sotera Health's Change in Accured Expenses amounted to $27.8 million in Q3 2025, which was up 7853.79% from -$4.3 million recorded in Q2 2025.
  • In the past 5 years, Sotera Health's Change in Accured Expenses registered a high of $27.8 million during Q3 2025, and its lowest value of -$33.7 million during Q3 2023.
  • Its 5-year average for Change in Accured Expenses is $2.4 million, with a median of $8.8 million in 2023.
  • In the last 5 years, Sotera Health's Change in Accured Expenses soared by 429495.41% in 2021 and then crashed by 132947.73% in 2022.
  • Over the past 5 years, Sotera Health's Change in Accured Expenses (Quarter) stood at $9.6 million in 2021, then soared by 134.52% to $22.5 million in 2022, then plummeted by 33.74% to $14.9 million in 2023, then tumbled by 31.95% to $10.1 million in 2024, then skyrocketed by 174.31% to $27.8 million in 2025.
  • Its last three reported values are $27.8 million in Q3 2025, -$4.3 million for Q2 2025, and -$10.2 million during Q1 2025.